These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2899433)

  • 1. In vitro studies on the interaction of famotidine with liver microsomal cytochrome P-450.
    Wang RW; Miwa GT; Argenbright LS; Lu AY
    Biochem Pharmacol; 1988 Aug; 37(15):3049-53. PubMed ID: 2899433
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of famotidine with rat liver microsomes, a study showing less inhibition of drug metabolism than with cimetidine.
    Imai Y; Inada M; Tamura S; Noda S; Kawata S; Minami Y; Tarui S
    Pharmacol Res Commun; 1986 Jul; 18(7):629-38. PubMed ID: 2876442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cimetidine, ranitidine and famotidine on rat hepatic microsomal cytochrome P-450 activities.
    Bast A; Smid K; Timmerman H
    Agents Actions; 1989 Apr; 27(1-2):188-91. PubMed ID: 2568738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of lovastatin--III. Effect of cimetidine and famotidine on in vitro metabolism of lovastatin by rat and human liver microsomes.
    Vyas KP; Kari PH; Wang RW; Lu AY
    Biochem Pharmacol; 1990 Jan; 39(1):67-73. PubMed ID: 2297361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of five structurally diverse H2-receptor antagonists on drug metabolism.
    Pasanen M; Arvela P; Pelkonen O; Sotaniemi E; Klotz U
    Biochem Pharmacol; 1986 Dec; 35(24):4457-61. PubMed ID: 2878667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the histamine H2-receptor antagonist etintidine with rat liver cytochrome P-450: a comparison with cimetidine.
    Schulz M; Schmoldt A
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):453-8. PubMed ID: 2893298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of nizatidine on drug metabolism.
    Klotz U
    Scand J Gastroenterol Suppl; 1987; 136():18-23. PubMed ID: 2892251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.
    Klotz U; Arvela P; Rosenkranz B
    Eur J Clin Pharmacol; 1985; 28(6):671-5. PubMed ID: 2866097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
    Carrasco M; Gaule C; Vega P; del Villar E
    Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of H2-receptor antagonists on drug interaction in rats.
    Lin JH; Cocchetto DM; Yeh KC; Duggan DE
    Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cimetidine with oxidized and prereduced microsomal cytochrome P-450.
    Faux SP; Combes RD
    Drug Metab Dispos; 1994; 22(1):180-2. PubMed ID: 8149882
    [No Abstract]   [Full Text] [Related]  

  • 12. On the sulphoxidation of cimetidine and etintidine by rat and human liver microsomes.
    Schulz M; Schmoldt A
    Xenobiotica; 1988 Aug; 18(8):983-9. PubMed ID: 3142156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents.
    Speeg KV; Patwardhan RV; Avant GR; Mitchell MC; Schenker S
    Gastroenterology; 1982 Jan; 82(1):89-96. PubMed ID: 6118315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of structural characteristics of some potential H2-receptor antagonists that determine the interaction with rat hepatic P-450.
    Rekka E; Sterk GJ; Timmerman H; Bast A
    Chem Biol Interact; 1988; 67(1-2):117-27. PubMed ID: 2901918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.
    Jensen JC; Gugler R
    Biochem Pharmacol; 1985 Jun; 34(12):2141-6. PubMed ID: 3924056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of human liver phenacetin O-deethylation by histamine and four histamine H2-receptor antagonists.
    Reilly PE; Mason SR; Gillam EM
    Xenobiotica; 1988 Apr; 18(4):381-7. PubMed ID: 2899931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of famotidine.
    Smith JL
    Digestion; 1985; 32 Suppl 1():15-23. PubMed ID: 2866132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P-450. Essential role of cytochrome P-450d.
    Jacobs JM; Sinclair PR; Bement WJ; Lambrecht RW; Sinclair JF; Goldstein JA
    Biochem J; 1989 Feb; 258(1):247-53. PubMed ID: 2930512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
    Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
    Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.